« Previous | 最新の10件 | Next »

アラバマ大学バーミンハム校・医学部・神経学科 ポスドク募集

アラバマ大学バーミンハム校・医学部・神経学科 アメリカ合衆国

当研究室では、一緒に研究してくれる意欲あふれるポスドクを1名募集します。
[ 募集人数 ] 1名
[ 応募資格 ] 医学、薬学、理学、工学、あるいは農学系博士号保持の方、または取得見込みの方
[ 待遇 ] NIHの規格による(社会保険完備)
[ 応募書類 ] 1) 履歴書と研究業績目録
       2) 推薦者3名(指導教官を含む)の連絡先(TEL, Email address)
[ 就任時期 ] できるだけ早い時期

以上の書類をemailにてYuqing Li (yli@uab.edu) まで送付してください。
候補者が決定次第締め切りとさせていただきます。
日本語でのお問い合わせは横井史章(yokoi@uab.edu)までお気軽にどうぞ。

当大学は、アメリカ中南部アラバマ州バーミンハムにあり、全米Top25に入る優秀な医学部です。バーミングハム市周辺は物価も安く、家族がおられる方にも安心してお勧めできます。
大学ランキング:
http://en.wikipedia.org/wiki/University_of_Alabama_School_of_Medicine#Rankings
アラバマ州バーミンハム市:
http://www.hia.jp/jp_sc_birmingham.html

A Postdoctoral position in molecular and translational neuroscience is available immediately to study pathophysiology of dystonia and to develop siRNA-based therapeutic treatment for DYT1 dystonia using genetically modified mouse models (Dang et al., Experimental Neurology, 196:452-463, 2005; Dang et al., Neuroscience Research, 56:470-4, 2006; Dang et al., PNAS USA, 103:15254-9, 2006; Hewett et al., PNAS USA, 104:7271-7276, 2007; Breakefield et al., Nature Review Neuroscience, 9, 222-234, 2008; Yokoi et al., J. Biochem. 143:39-47, 2008). Dystonia is defined clinically as involuntary, often sustained co-contraction of agonist and antagonist muscles causing abnormal and often painful postures or movements. It is generally believed to be mediated by the central nervous system and represents the third most common movement disorders after Parkinson's disease and tremor. The project involves using transgenic mouse models to study pathophysiology of dystonia/Parkinson disease and using siRNA/shRNA and pharmacological reagents to develop effective treatments for dystonia and other related movement disorders. Highly motivated candidates with solid publication record in reputable journals in the area of molecular biology, cell biology, histology, cell culture, or mouse behavioral analysis are encouraged to apply. Experience in molecular or cell biology is desirable and knowledge in neuroscience or neurology is a plus. To apply, please send a CV, and names and contact addresses of references to: Dr. Yuqing Li, Department of Neurology, School of Medicine, University of Alabama at Birmingham, 560 Civitan International Research Center, 1719 6th Avenue South, Birmingham, AL 35294-0021. Email: yli@uab.edu, Tel. +1-205-996-6299, Fax. +1-205-996-7200. The Department of Neurology and the University of Alabama at Birmingham have established a Center for Neurodegeneration and Experimental Therapeutics, a state-of-art facility to accelerate discovery and to bring treatment to patients. Further, a new Comprehensive Neuroscience Center was established last year and it provides advanced research services and extensive inter-disciplinary interactions. Further information about Dr. Li, the UAB Department of Neurology, and the Center for Neurodegeneration and Experimental Therapeutics, the Comprehensive Neuroscience Center, and related information about training environment may be found at the following Web sites:
http://main.uab.edu/neurology/Templates/Inner.aspx?pid=99179
http://138.26.61.118/depts/MEB/SOMResearchFaculty/currentfacultydata.asp?ID=yli
http://www.cnc.uab.edu
http://main.uab.edu/neurology/Templates/Inner.aspx?pid=104130
http://www.postdocs.uab.edu/

投稿者:Yuqing Li(yli@uab.edu)

« Previous | 最新の10件 | Next »

アーカイブ

  • 2011年02月
  • 2011年01月
  • 2010年12月
  • 過去ログ一覧